Brian T.  Griffin net worth and biography

Brian Griffin Biography and Net Worth

Brian T. Griffin serves as Independent Director of the Company. Mr. Griffin has a proven track record of over 35 years of senior leadership and operational experience in healthcare. He most recently served as Chairman and Chief Executive Officer of Diplomat Pharmacy Inc., one of the nation's largest independent Specialty Pharmacies and Pharmacy Benefit Managers (PBM), until it was recently acquired by UnitedHealth Group Inc. (NYSE: UNH). Previously, Mr. Griffin joined Anthem (NYSE: ANTM), in 2013, initially as President and Chief Executive Officer of its Empire BlueCross BlueShield - New York Company, and ultimately assuming the role of President of Anthem's Commercial Business, including its 14 BlueCross BlueShield plans nationwide. Thereafter, Mr. Griffin was named Chief Executive Officer of IngenioRx, Anthem's wholly owned national PBM. Mr. Griffin also held positions of increasing responsibility with Medco Health Solutions, Inc. and US Healthcare, Inc.

What is Brian T. Griffin's net worth?

The estimated net worth of Brian T. Griffin is at least $13.68 million as of May 3rd, 2018. Mr. Griffin owns 25,619 shares of Elevance Health stock worth more than $13,675,166 as of April 25th. This net worth evaluation does not reflect any other investments that Mr. Griffin may own. Learn More about Brian T. Griffin's net worth.

How do I contact Brian T. Griffin?

The corporate mailing address for Mr. Griffin and other Elevance Health executives is 220 VIRGINIA AVENUE, INDIANAPOLIS IN, 46204. Elevance Health can also be reached via phone at (800) 331-1476 and via email at [email protected]. Learn More on Brian T. Griffin's contact information.

Has Brian T. Griffin been buying or selling shares of Elevance Health?

Brian T. Griffin has not been actively trading shares of Elevance Health during the last ninety days. Most recently, Brian T. Griffin sold 59,421 shares of the business's stock in a transaction on Thursday, May 3rd. The shares were sold at an average price of $224.41, for a transaction totalling $13,334,666.61. Following the completion of the sale, the chief executive officer now directly owns 25,619 shares of the company's stock, valued at $5,749,159.79. Learn More on Brian T. Griffin's trading history.

Who are Elevance Health's active insiders?

Elevance Health's insider roster includes Gail Boudreaux (CEO), Robert Dixon, Jr. (Director), John Gallina (CFO), Brian Griffin (CEO), Peter Haytaian (EVP), Julie Hill (Director), Charles Kendrick, Jr. (EVP), Gloria Mccarthy (EVP), Ronald Penczek (CAO), Ramiro Peru (Director), Craig Samitt (EVP), Ryan Schneider (Director), Joseph Swedish (Insider), Jose Tomas (EVP), and Thomas Zielinski (EVP). Learn More on Elevance Health's active insiders.

Are insiders buying or selling shares of Elevance Health?

In the last year, insiders at the sold shares 3 times. They sold a total of 1,127 shares worth more than $553,358.50. The most recent insider tranaction occured on February, 7th when Director Ramiro G Peru sold 753 shares worth more than $376,500.00. Insiders at Elevance Health own 0.3% of the company. Learn More about insider trades at Elevance Health.

Information on this page was last updated on 2/7/2024.

Brian T. Griffin Insider Trading History at Elevance Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/3/2018Sell59,421$224.41$13,334,666.6125,619View SEC Filing Icon  
See Full Table

Brian T. Griffin Buying and Selling Activity at Elevance Health

This chart shows Brian T Griffin's buying and selling at Elevance Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Elevance Health Company Overview

Elevance Health logo
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.
Read More

Today's Range

Now: $533.79
Low: $527.28
High: $534.86

50 Day Range

MA: $510.78
Low: $497.60
High: $533.79

2 Week Range

Now: $533.79
Low: $412.00
High: $539.11

Volume

895,401 shs

Average Volume

1,114,123 shs

Market Capitalization

$124.06 billion

P/E Ratio

20.17

Dividend Yield

1.22%

Beta

0.78